|
Volumn 21, Issue 6 A, 2001, Pages 4025-4030
|
TAC-101, a novel retinobenzoic-acid derivative, enhances gap junctional intercellular communication among renal epithelial cells treated with renal carcinogens
a a a a a a |
Author keywords
Connexin; Gap junction; Renal cell carcinoma; TAC 101
|
Indexed keywords
4 [3,5 BIS(TRIMETHYLSILYL)BENZAMIDO]BENZOIC ACID;
BENZOIC ACID DERIVATIVE;
GAP JUNCTION PROTEIN;
RETINOIC ACID RECEPTOR;
RETINOID;
TAC 101;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL;
CELL COMMUNICATION;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG EFFECT;
GAP JUNCTION;
KIDNEY CARCINOMA;
KIDNEY EPITHELIUM;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN LOCALIZATION;
PROTEIN PHOSPHORYLATION;
RECEPTOR BINDING;
SIGNAL TRANSDUCTION;
ANIMALS;
ANTICARCINOGENIC AGENTS;
BENZOATES;
BLOTTING, WESTERN;
BROMIDES;
CARCINOGENS;
CELL COMMUNICATION;
CELL DIVISION;
CELL MEMBRANE PERMEABILITY;
CONNEXIN 43;
DIMETHYLNITROSAMINE;
DOGS;
DRUG INTERACTIONS;
EPITHELIAL CELLS;
FLUORESCENT ANTIBODY TECHNIQUE;
GAP JUNCTIONS;
KIDNEY;
KIDNEY NEOPLASMS;
PHOSPHORYLATION;
POTASSIUM COMPOUNDS;
TRIMETHYLSILYL COMPOUNDS;
UP-REGULATION;
|
EID: 0035569904
PISSN: 02507005
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (20)
|